CN Stock MarketDetailed Quotes

000627 Hubei Biocause Pharmaceutical

Watchlist
  • 3.60
  • 0.000.00%
Not Open Jan 7 09:30 CST
17.79BMarket Cap-23.08P/E (TTM)

Hubei Biocause Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Biocause Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
4.54B
--
-41.49%
EPS
--
<0.01
--
--
Analyst Rating
No Data

Hubei Biocause Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

No Data

Hubei Biocause Pharmaceutical Earnings Reports

  • Tianmao Group: Report for the third quarter of 2024

    Oct 30, 2024 12:00 ET

  • Tianmao Group: Tianmao Group\'s performance forecast for the first three quarters of 2024

    Oct 14, 2024 12:00 ET

  • Tianmao Group: Guohua Life 2024 Semi-Annual Report

    Aug 30, 2024 12:00 ET

  • Tianmao Group: 2024 Semi-Annual Report

    Aug 30, 2024 12:00 ET

    • Read more

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data